Full-Service CDMO for a Global Market
Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides - Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
- >> Full-Service CDMO Organized under 5 Technology Platforms
- >> 8 cGMP Manufacturing Facilities in Europe / US and 1 R&D Research Laboratory
- >> 1,900 Employees
CordenPharma is a full-service partner in the cGMP Contract Development & Manufacturing of Active Pharmaceutical Ingredients (APIs), Drug Products and Pharma Packaging Services, supporting leading pharmaceutical & biotechnology companies to achieve product success for their patients’ healthier lives.
CordenPharma Acquisition History by ICIG
|CordenPharma Facility||Legacy Company||Year Acquired|
|CordenPharma Chenôve||Abbott / Solvay||12 / 2007|
|CordenPharma Plankstadt||AstraZeneca||1 / 2008|
|CordenPharma Caponago||AstraZeneca||6 / 2009|
|CordenPharma Switzerland||Sanofi / Genzyme||2 / 2011|
|CordenPharma Colorado||Roche||8 / 2011|
|CordenPharma Bergamo||Tessenderlo / Farchemia||12 / 2012|
|CordenPharma Brussels||Solvay / Peptisyntha||11 / 2013|
|CordenPharma Boulder||Pfizer / Hospira||10 / 2017|